Based on end users the genomics market is segmented into hospitals & clinics, research centers and academic & government institutes, pharmaceutical & biotechnology companies, and other end users.

Partnerships and collaborations for technological advancements in genomics, and impact of COVID-19 on genomics increased the demand of genomics in market.

High cost of genomic instruments and the possibility of instrument obsolescence have driven end users to outsource their sequencing needs.